Autonomix Medical 주식 가격. AMIX - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

6.375

매수가

6.35

매도가

6.40

거래량

487,534

5.85 일간 변동폭 6.66

5.85 52주 범위 152.00

market_cap

7.345M

전일 종가

13.52

개장가

6.20

최근 거래 시간

6.375

마지막 거래 시간

00:15:24

재정 규모

US$ 3,060,784

VWAP

6.2781

평균 볼륨(3m)

759,566

발행 주식

1,152,149

배당수익률

주가수익률

-0.49

주당순이익(EPS)

-13.39

매출

순이익

-15.43M

Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pan... Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. 더 보기

섹터

Surgical,med Instr,apparatus

산업

Surgical,med Instr,apparatus

웹사이트

autonomix.com

본부

Dover, Delaware, USA

설립됨

Autonomix Medical Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker AMIX. The last closing price for Autonomix Medical was US$13.52. Over the last year, Autonomix Medical shares have traded in a share price range of US$ 5.85 to US$ 152.00.

Autonomix Medical currently has 1,152,149 shares in issue. The market capitalisation of Autonomix Medical is US$15.58 million. Autonomix Medical has a price to earnings ratio (PE ratio) of -0.49.

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

THE WOODLANDS, TX, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Ongoing proof-of-concept (PoC) clinical trial in pain associated with pancreatic cancer; Preliminary results demonstrate 100% of the lead-in patient responder group went to zero opioid use at 4-6...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form S-1 - General form for registration of securities under the Securities Act of 1933

Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction

79% responder rate achieved with zero opioid use and quality of life improvement at 7 days post-procedure Company reaches 60% enrollment with 15 patients1 successfully enrolled; No unexpected...

Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Access the Virtual Investor “What This Means” Segment here THE WOODLANDS, TX, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...

Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial

100% of the responder group went to zero opioid use at 4-6 weeks post-procedure Up to 75% of late-stage pancreatic cancer patients are prescribed opioids and data suggests 20% are at risk for...

Form 8-K - Current report

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-3.3848	-34.6810385459	9.7598	14.06	5.85	125357	12.57412649	CS
4	-1.595	-20.0125470514	7.97	19.3	5.85	1468572	12.77908487	CS
12	-5.125	-44.5652173913	11.5	19.3	5.85	759566	13.15829074	CS
26	-39.025	-85.9581497797	45.4	56	5.85	2628706	24.0121727	CS
52	-145.625	-95.8059210526	152	152	5.85	1641105	24.76183159	CS
156	-145.625	-95.8059210526	152	152	5.85	1641105	24.76183159	CS
260	-145.625	-95.8059210526	152	152	5.85	1641105	24.76183159	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
SKKSKK Holdings Limited	US$ 2.035 (85.00%)	60.1M
DEVSDevvStream Corporation	US$ 0.8151 (62.37%)	36.83M
REPLReplimune Group Inc	US$ 15.269 (38.18%)	2.36M
PDYNPalladyne AI Corporation	US$ 2.7469 (37.35%)	3.76M
WCTWellchange Holdings Company Limited	US$ 1.6894 (35.15%)	30.85M
AMIXAutonomix Medical Inc	US$ 6.35 (-53.03%)	487.16k
APTOAptose Biosciences Inc	US$ 0.1398 (-42.70%)	6M
CETXCemtrex Inc	US$ 0.1177 (-40.16%)	10.14M
KSCPKnightscope Inc	US$ 13.7619 (-24.76%)	383.62k
RMSGReal Messenger Corporation	US$ 3.17 (-24.34%)	131.85k
ELABElevai Labs Inc	US$ 0.01905 (-5.69%)	137.18M
VRPXVirpax Pharmaceuticals Inc	US$ 0.7785 (32.02%)	116.67M
SKKSKK Holdings Limited	US$ 2.035 (85.00%)	60.1M
NVDANVIDIA Corporation	US$ 142.7399 (-2.68%)	53.09M
SMCISuper Micro Computer Inc	US$ 32.80 (10.44%)	51.69M